Details for 2022189129
Up to date per 02.04.2026
Actions
Details for 2022189129
Granted/Registered
European Patent
21.12.2022 A
27.09.2023 B1
18.06.2009
US
26895409 P
A61K 38/095 20190101AFI20230512BHEP
Owner
Acerus Pharmaceuticals USA, LLC500 Office Center Drive Suite 400 Fort Washington, PA 19034US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
FEIN, Seymour New Canaan, ConnecticutUS
Information about Fees